tiprankstipranks
Intellia Therapeutics (DE:38I)
FRANKFURT:38I
Germany Market
Want to see DE:38I full AI Analyst Report?

Intellia Therapeutics (38I) Technical Analysis

13 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Intellia Therapeutics’s (38I) Moving Averages Convergence Divergence (MACD) indicator is 0.24, suggesting Intellia Therapeutics is a Sell.
Intellia Therapeutics’s (38I) 20-Day exponential moving average is 11.50, while Intellia Therapeutics’s (38I) share price is €11.7, making it a Buy.
Intellia Therapeutics’s (38I) 50-Day exponential moving average is 11.12, while Intellia Therapeutics’s (38I) share price is €11.7, making it a Buy.

Intellia Therapeutics (38I) Pivot Points

May 08, 2026, 04:19 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.24
11.52
11.66
11.94
12.08
12.36
12.50
Fibonacci
11.52
11.68
11.78
11.94
12.10
12.20
12.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intellia Therapeutics (38I) Moving Averages

May 08, 2026, 04:19 PM
Period
Simple
Exponential
MA5
11.96Sell
11.83Sell
MA10
11.68Buy
11.70Buy
MA20
11.35Buy
11.50Buy
MA50
11.05Buy
11.12Buy
MA100
10.01Buy
10.83Buy
MA200
11.04Buy
10.52Buy
Intellia Therapeutics’s (38I) 10-Day exponential moving average is 11.70, while Intellia Therapeutics’s (38I) share price is €11.7, making it a Buy.
Intellia Therapeutics’s (38I) 100-Day exponential moving average is 10.83, while Intellia Therapeutics’s (38I) share price is €11.7, making it a Buy.
Intellia Therapeutics’s (38I) stock price is €11.7 and Intellia Therapeutics’s (38I) 50-day simple moving average is 11.05, creating a Buy signal.
Intellia Therapeutics’s (38I) stock price is €11.7 and Intellia Therapeutics’s (38I) 100-day simple moving average is 10.01, creating a Buy signal.
Intellia Therapeutics’s (38I) stock price is €11.7 and Intellia Therapeutics’s (38I) 200-day simple moving average is 11.04, creating a Buy signal.

Intellia Therapeutics (38I) Technical Indicators

May 08, 2026, 04:19 PM
Name
Value
Implied Action
RSI (14)
52.39
Neutral
STOCH (9,6)
70.72
Neutral
STOCHRSI (14)
83.66
Sell
MACD (12,26)
0.24
Sell
ADX (14)
26.97
Neutral
Williams %R
-26.40
Buy
CCI (14)
53.23
Neutral
ATR (14)
0.57
-
Ultimate Oscillator
51.91
Neutral
ROC
-4.88
Sell
Intellia Therapeutics’s (38I) Relative Strength Index (RSI) is 52.39, creating a Neutral signal.
Intellia Therapeutics’s (38I) Trend Strength Indicator (ADX) is 26.97, creating a Neutral signal.
Intellia Therapeutics’s (38I) Commodity Channel Index (CCI) is 53.23, creating a Neutral signal.
Intellia Therapeutics’s (38I) Price Rate of Change (ROC) is -4.88, creating a Sell signal.

FAQ

Is 38I a Buy, Hold, or Sell?
Based on 38I’s technical indicators, 38I is a Buy.
    What is 38I’s RSI (14)?
    38I’s RSI (14) is 52.39, which suggests 38I is a Neutral.
      What is 38I’s MACD?
      38I’s MACD is 0.24, which suggests 38I is a Sell.
        What is 38I’s 5-day moving average?
        38I’s 5-day moving average is 11.96, which suggests 38I is a Sell.
          What is 38I’s 20-day moving average?
          38I 20-day moving average is 11.35, which suggests 38I is a Buy.
            What is 38I’s 50-day moving average?
            38I’s 50-day moving average is 11.05, which suggests 38I is a Buy.
              What is 38I’s 200-day moving average?
              38I’s 200-day moving average is 11.04, which suggests 38I is a Buy.
                What is 38I’s Williams % R (14)?
                38I’s Williams % R (14) is -26.40, which suggests 38I is a Buy.
                  What is 38I’s CCI (14)?
                  38I’s CCI (14) is 53.23, which suggests 38I is a Neutral.
                    What is the share price of Intellia Therapeutics?